한글목차

세계의 RNA 추출 및 정제 시장 전망은 병원 및 진단센터 시장과 학술 및 연구 기관 시장에서의 기회로 인해 유망한 전망을 보이고 있습니다. 세계의 RNA 추출 및 정제 시장은 2025-2031년 7.2%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 유전자 연구에 대한 수요 증가, 감염성 질환의 확산, 분자진단 기술의 채택 확대 등입니다.

• Lucintel의 예측에 따르면, 제품별로는 키트 및 시약이 예측 기간 동안 높은 성장률을 보일 것으로 예측됩니다.
• 최종 용도별로는 학술 및 연구기관 분야가 더 높은 성장률을 보일 것으로 예측됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예측됩니다.

RNA 추출 및 정제 시장의 새로운 동향

RNA 추출 및 정제 시장은 생명공학 기술의 발전, 개인 맞춤형 의료에 대한 수요 증가, RNA 기반 연구의 응용 확대에 따라 빠르게 성장하고 있습니다. 이 분야가 진화함에 따라 몇 가지 새로운 트렌드가 시장 전망상을 형성하고 있습니다. 이러한 추세는 기술 혁신, 연구 우선순위의 변화, 보다 효율적이고 정확하며 확장성이 높은 솔루션에 대한 요구를 반영하고 있습니다. RNA 추출 및 정제 분야에서 경쟁력을 유지하고 새로운 기회를 활용하고자 하는 이해관계자들에게 이러한 동향을 이해하는 것은 매우 중요합니다. 다음은 이 역동적인 시장에 영향을 미치는 주요 방향성을 제시하는 주요 동향을 정리한 것입니다.

• 자동화 및 하이스루풋 기술: 자동화와 하이스루풋 시스템의 통합은 RNA 추출 프로세스에 혁명을 일으키고 있습니다. 자동화 플랫폼은 수작업을 줄이고 오류를 최소화하며 시료 처리 속도를 향상시켜 실험실에서 대량의 시료를 효율적으로 처리할 수 있도록 도와줍니다. 이러한 추세는 신속하고 신뢰할 수 있는 RNA 정제가 필수적인 임상 진단 및 대규모 연구 프로젝트에서 특히 큰 영향을 미치고 있습니다. 기술의 발전과 함께 보다 사용자 친화적이고 비용 효율적인 자동화 솔루션이 표준화되면서 업계 전반의 생산성과 일관성이 크게 향상될 것으로 기대됩니다.
• 새로운 추출 키트 및 시약 개발: 추출 키트 및 시약의 혁신은 주요 트렌드이며, 수율, 순도 및 다운스트림 용도과의 호환성 향상에 초점을 맞추었습니다. 새로운 배합은 FFPE 조직이나 저투입 시료와 같이 다루기 어려운 시료 유형에도 대응할 수 있도록 설계되어 RNA 조사 범위를 확대할 수 있습니다. 이러한 발전을 통해 연구자들은 오염과 분해 문제를 줄이면서 고품질의 RNA를 보다 효율적으로 얻을 수 있게 되었습니다. 전문 키트의 가용성은 유전체학, 전사체학, 맞춤의료 등의 분야에서 성장을 가속하고 다양한 연구 수요를 지원합니다.
• RNA의 품질과 무결성에 대한 중요성: 고품질의 완전한 RNA를 확보하는 것은 시퀀싱 및 유전자 발현 분석과 같은 고감도 용도에서 특히 중요한 초점이 되고 있습니다. 새로운 트렌드로는 시료 채취 및 처리 과정에서 RNA 무결성을 유지하는 보존법 및 추출 프로토콜의 개발이 꼽힙니다. 품질 관리 강화와 표준화 절차의 중요성도 높아지고 있으며, 이러한 노력은 실험 결과의 신뢰성 향상과 변동성 감소에 기여하고 정밀 분자진단 및 연구에 대한 수요 증가를 뒷받침하여 시장의 전반적인 수준 향상에 기여하고 있습니다.
• Point-of-Care 및 현장 배치형 솔루션의 확대: 원격지 및 자원이 제한된 환경에서 신속한 진단이 필요하기 때문에 휴대가 간편하고 사용하기 쉬운 RNA 추출 장비에 대한 수요가 증가하고 있습니다. 포인트 오브 케어 솔루션은 감염증의 현장 검사, 발병 모니터링, 맞춤 치료 판단을 가능하게 합니다. 이 컴팩트한 시스템은 최소한의 시료 준비와 빠른 결과 제공을 목적으로 설계되어 분자 검사에 대한 접근성을 확대합니다. 기술 혁신으로 이러한 추세는 가속화될 것으로 예상되며, RNA 기반 진단은 기존의 실험실 환경을 넘어 보다 광범위한 의료 현장과 야외 응용 분야로 확대될 것으로 예측됩니다.
• AI와 데이터 분석의 통합: 인공지능(AI)과 고급 데이터 분석 기술이 프로토콜 최적화 및 결과 예측을 위해 RNA 추출 워크플로우에 통합되는 사례가 증가하고 있습니다. AI 기반 알고리즘은 샘플 데이터를 분석하여 최적의 추출 방법을 제안하고, 문제를 해결하며, 수율과 순도를 향상시킵니다. 이러한 추세는 재현성 향상, 비용 절감, 조사 일정 단축을 가져옵니다. 또한, AI 도구는 대규모 데이터 관리 및 해석을 지원하고, 복잡한 전사체 연구를 지원합니다. AI의 도입은 현대 분자생물학 연구의 요구에 따라 보다 스마트하고 효율적인 RNA 추출 프로세스를 실현함으로써 시장을 변화시키고 있습니다.

요약하면, 이러한 새로운 트렌드는 프로세스를 보다 효율적이고, 확장 가능하며, 접근성이 용이하게 함으로써의 RNA 추출 및 정제 시장 전체를 재구성하고 있습니다. 이를 통해 혁신을 촉진하고, 품질 기준을 개선하고, 적용 범위를 확대하며, 궁극적으로 개인 맞춤형 의료, 진단 및 첨단 연구의 성장을 지원합니다. 이러한 트렌드가 계속 진화하면서 시장은 큰 변화를 맞이하고 있으며, 업계 관계자와 연구자 모두에게 새로운 기회를 제공합니다.

RNA 추출 및 정제 시장의 최근 동향

RNA 추출 및 정제 시장은 분자생물학의 발전, 진단 검사에 대한 수요 증가, RNA 기반 연구의 응용 확대에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 코로나19 팬데믹은 빠르고 신뢰할 수 있는 RNA 추출 방법의 필요성을 가속화하고 효율적인 기술의 중요성을 부각시켰습니다. 또한, 자동화 기술 혁신, 신규 시약 개발, 하이스루풋 시스템 통합이 시장 상황을 변화시키고 있습니다. 이러한 발전은 정확도 향상, 처리 시간 단축, 응용 분야 확대를 통해 시장 전망를 형성하고 있습니다. 다음은 이 시장에 영향을 미치는 5가지 주요 최근 동향을 소개합니다.

• 자동화 기술: RNA 추출 공정에 자동화를 통합하여 효율성과 재현성을 향상시켰습니다. 자동화 시스템은 수작업으로 인한 오류를 줄이고, 처리 능력을 높여 대량 처리가 가능합니다. 이는 임상 진단 및 연구소에 매우 중요합니다. 이러한 변화는 인건비 절감, 처리 시간 단축, 다양한 환경에서의 RNA 추출을 보다 쉽게 이용할 수 있고 신뢰할 수 있게 되었습니다.
• 신규 추출 시약: 혁신적인 시약 개발로 RNA의 수율과 순도가 향상되었습니다. 이 시약들은 효율이 높고, 독성이 낮으며, 다운스트림 공정과의 호환성을 고려하여 설계되었습니다. 그 도입으로 특히 FFPE 조직이나 혈액과 같은 어려운 시료에서 RNA 추출 키트의 적용 범위가 확대되어 연구 및 진단 용도의 폭이 넓어졌습니다.
• 하이스루풋 플랫폼: 하이스루풋 추출 플랫폼의 도입은 유전체학, 전사체학 등 대규모 연구에 혁명을 일으켰습니다. 이러한 플랫폼은 여러 시료를 동시에 처리할 수 있어 시간과 비용을 크게 절감할 수 있습니다. 특히 임상시험이나 대규모 코호트 연구에서 영향력이 크고, 신속한 데이터 생성 및 분석을 촉진하고 있습니다.
• 코로나19의 영향: 팬데믹은 SARS-CoV-2 검사에서 신속하고 신뢰할 수 있는 RNA 추출 방법의 중요성을 부각시켰습니다. 이로 인해 더 빠르고 민감한 추출 키트 및 프로토콜 개발에 대한 투자가 증가했습니다. 수요의 급증은 혁신을 가속화하고 시장 규모를 확대하여 RNA 추출을 감염성 질환 진단의 중요한 요소로 확립했습니다.
• 규제 및 품질 기준: 엄격한 규제 요건과 품질 기준은 표준화되고 검증된 추출 키트의 개발을 촉진해 왔습니다. 이러한 기준 준수는 임상 진단 및 연구에 필수적인 결과의 신뢰성과 재현성을 보장합니다. 이러한 품질 중심적 태도는 신뢰를 쌓아가고 있으며, 특히 규제가 엄격한 의료 환경에서 시장 성장을 가속하고 있습니다.

요약하면, 자동화, 신규 시약, 하이스루풋 시스템, 팬데믹을 계기로 한 혁신, 규제 기준 등 최근 트렌드가의 RNA 추출 및 정제 시장을 크게 변화시키고 있습니다. 이러한 발전은 효율성, 정확성, 확장성을 향상시키고, 연구 및 임상 분야 모두에서 적용 범위를 확대하여 시장 성장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 RNA 추출 및 정제 시장 : 제품별

• 매력 분석 : 제품별
• 키트 및 시약
• 장비

제5장 세계의 RNA 추출 및 정제 시장 : 최종 용도별

• 매력 분석 : 최종 용도별
• 병원 및 진단센터
• 학술기관 및 연구기관
• 기타

제6장 지역 분석

제7장 북미의 RNA 추출 및 정제 시장

• 북미의 RNA 추출 및 정제 시장 : 제품별
• 북미의 RNA 추출 및 정제 시장 : 최종 용도별
• 미국의 RNA 추출 및 정제 시장
• 멕시코의 RNA 추출 및 정제 시장
• 캐나다의 RNA 추출 및 정제 시장

제8장 유럽의 RNA 추출 및 정제 시장

• 유럽의 RNA 추출 및 정제 시장 : 제품별
• 유럽의 RNA 추출 및 정제 시장 : 최종 용도별
• 독일의 RNA 추출 및 정제 시장
• 프랑스의 RNA 추출 및 정제 시장
• 스페인의 RNA 추출 및 정제 시장
• 이탈리아의 RNA 추출 및 정제 시장
• 영국의 RNA 추출 및 정제 시장

제9장 아시아태평양의 RNA 추출 및 정제 시장

• 아시아태평양의 RNA 추출 및 정제 시장 : 제품별
• 아시아태평양의 RNA 추출 및 정제 시장 : 최종 용도별
• 일본의 RNA 추출 및 정제 시장
• 인도의 RNA 추출 및 정제 시장
• 중국의 RNA 추출 및 정제 시장
• 한국의 RNA 추출 및 정제 시장
• 인도네시아의 RNA 추출 및 정제 시장

제10장 기타 지역(ROW)의 RNA 추출 및 정제 시장

• 기타 지역의 RNA 추출 및 정제 시장 : 제품별
• 기타 지역의 RNA 추출 및 정제 시장 : 최종 용도별
• 중동의 RNA 추출 및 정제 시장
• 남미의 RNA 추출 및 정제 시장
• 아프리카의 RNA 추출 및 정제 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계 RNA 추출 및 정제 시장의 새로운 동향
• 전략 분석

제13장 밸류체인 주요 기업 개요

• 경쟁 분석 : 개요
• Agilent Technologies
• Bio Rad Laboratories
• Danaher
• F. Hoffmann La Roche
• Geno Technology
• HiMedia Laboratories
• Illumina
• New England Biolabs
• Norgen Biotek
• Promega

제14장 부록

영문목차

The future of the global RNA extraction and purification market looks promising with opportunities in the hospital & diagnostic center and academic research institute markets. The global RNA extraction and purification market is expected to grow with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the increasing demand for genetic research, the rising prevalence of infectious diseases, and the growing adoption of molecular diagnostics.

• Lucintel forecasts that, within the product category, kit & reagent is expected to witness higher growth over the forecast period.
• Within the end use category, academic research institute is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the RNA Extraction and Purification Market

The RNA extraction and purification market is experiencing rapid growth driven by advancements in biotechnology, increasing demand for personalized medicine, and the expanding applications of RNA-based research. As the field evolves, several emerging trends are shaping the future landscape of this market. These trends reflect technological innovations, shifts in research priorities, and the need for more efficient, accurate, and scalable solutions. Understanding these developments is crucial for stakeholders aiming to stay competitive and leverage new opportunities in RNA extraction and purification. The following key trends highlight the major directions influencing this dynamic market.

• Automation and High-Throughput Technologies: The integration of automation and high-throughput systems is revolutionizing RNA extraction processes. Automated platforms reduce manual labor, minimize errors, and increase sample processing speed, enabling laboratories to handle large sample volumes efficiently. This trend is particularly impactful in clinical diagnostics and large-scale research projects, where rapid and reliable RNA purification is essential. As technology advances, more user-friendly and cost-effective automated solutions are expected to become standard, significantly enhancing productivity and consistency across the industry.
• Development of Novel Extraction Kits and Reagents: Innovation in extraction kits and reagents is a key trend, focusing on improving yield, purity, and compatibility with downstream applications. New formulations are designed to work with challenging sample types, such as FFPE tissues and low-input samples, broadening the scope of RNA research. These advancements help researchers obtain high-quality RNA more efficiently, reducing contamination and degradation issues. The availability of specialized kits supports diverse research needs, fostering growth in areas like genomics, transcriptomics, and personalized medicine.
• Emphasis on RNA Quality and Integrity: Ensuring high-quality, intact RNA remains a critical focus, especially for sensitive applications like sequencing and gene expression analysis. Emerging trends include the development of preservation methods and extraction protocols that maintain RNA integrity during sample collection and processing. Improved quality control measures and standardized procedures are also gaining importance. These efforts enhance the reliability of experimental results, reduce variability, and support the growing demand for precise molecular diagnostics and research, ultimately elevating the overall standards of the market.
• Expansion of Point-of-Care and Field-Deployable Solutions: The demand for portable, easy-to-use RNA extraction devices is increasing, driven by the need for rapid diagnostics in remote or resource-limited settings. Point-of-care solutions enable on-site testing for infectious diseases, outbreak monitoring, and personalized treatment decisions. These compact systems are designed for minimal sample preparation and quick turnaround times, making molecular testing more accessible. The trend is expected to accelerate with technological innovations, expanding the reach of RNA-based diagnostics beyond traditional laboratory environments and into broader healthcare and field applications.
• Integration of AI and Data Analytics: Artificial intelligence (AI) and advanced data analytics are increasingly being integrated into RNA extraction workflows to optimize protocols and predict outcomes. AI-driven algorithms can analyze sample data to recommend the best extraction methods, troubleshoot issues, and improve yield and purity. This trend enhances reproducibility, reduces costs, and accelerates research timelines. Additionally, AI tools facilitate large-scale data management and interpretation, supporting complex transcriptomic studies. The adoption of AI is transforming the market by enabling smarter, more efficient RNA extraction processes aligned with the needs of modern molecular biology research.

In summary, these emerging trends are collectively reshaping the RNA extraction and purification market by making processes more efficient, scalable, and accessible. They are driving innovation, improving quality standards, and expanding the application scope, ultimately supporting the growth of personalized medicine, diagnostics, and advanced research. As these trends continue to evolve, the market is poised for significant transformation, offering new opportunities for industry players and researchers alike.

Recent Developments in the RNA Extraction and Purification Market

The RNA extraction and purification market has experienced significant growth driven by advancements in molecular biology, increased demand for diagnostic testing, and the expanding applications of RNA-based research. The COVID-19 pandemic accelerated the need for rapid and reliable RNA extraction methods, highlighting the importance of efficient technologies. Additionally, innovations in automation, the development of new reagents, and the integration of high-throughput systems have transformed the landscape. These developments are shaping the future of the market by improving accuracy, reducing processing time, and expanding application areas. The following are five key recent developments impacting this market.

• Automation Technologies: The integration of automation in RNA extraction processes has enhanced efficiency and reproducibility. Automated systems reduce manual errors, increase throughput, and enable high-volume processing, which is crucial for clinical diagnostics and research laboratories. This shift has lowered labor costs and improved turnaround times, making RNA extraction more accessible and reliable across various settings.
• Novel Extraction Reagents: The development of innovative reagents has improved RNA yield and purity. These reagents are designed to be more efficient, less toxic, and compatible with downstream applications. Their introduction has expanded the usability of RNA extraction kits, especially in challenging samples like FFPE tissues and blood, thereby broadening the scope of research and diagnostic applications.
• High-Throughput Platforms: The adoption of high-throughput extraction platforms has revolutionized large-scale studies, such as genomics and transcriptomics. These platforms enable simultaneous processing of multiple samples, significantly reducing time and costs. They are particularly impactful in clinical trials and large cohort studies, facilitating rapid data generation and analysis.
• COVID-19 Impact: The pandemic underscored the critical need for rapid, reliable RNA extraction methods for SARS-CoV-2 testing. This led to increased investments in developing faster, more sensitive extraction kits and protocols. The surge in demand accelerated innovation and expanded market capacity, establishing RNA extraction as a vital component of infectious disease diagnostics.
• Regulatory and Quality Standards: Stringent regulatory requirements and quality standards have driven the development of standardized, validated extraction kits. Compliance with these standards ensures reliability and reproducibility of results, which is essential for clinical diagnostics and research. This focus on quality has fostered trust and facilitated market growth, especially in regulated healthcare environments.

In summary, recent developments such as automation, novel reagents, high-throughput systems, pandemic-driven innovations, and regulatory standards are significantly transforming the RNA extraction and purification market. These advancements are improving efficiency, accuracy, and scalability, thereby expanding applications and driving market growth across research and clinical sectors.

Strategic Growth Opportunities in the RNA Extraction and Purification Market

The RNA extraction and purification market is experiencing rapid growth driven by advancements in biotechnology, personalized medicine, and diagnostic applications. As the demand for high-quality RNA samples increases across various sectors, key applications are emerging as significant growth drivers. These opportunities are transforming the landscape by enabling more accurate diagnostics, efficient research, and innovative therapies. Companies are investing heavily in developing specialized extraction techniques tailored to specific applications, which is expanding market reach and enhancing product offerings. The following are five key growth opportunities across different applications that are shaping the future of this market.

• Clinical Diagnostics: Improved disease detection and personalized treatment options are fueling demand for rapid, reliable RNA extraction methods. This enhances diagnostic accuracy, especially in infectious diseases and cancer, leading to better patient outcomes and supporting the growth of molecular testing laboratories.
• Pharmaceutical & Biotech Research: The need for high-quality RNA in drug discovery and development is increasing. Advanced extraction techniques enable researchers to perform gene expression analysis and biomarker discovery more efficiently, accelerating the development of targeted therapies and personalized medicine.
• Academic & Research Institutions: Growing investment in life sciences research is driving demand for cost-effective, scalable RNA extraction solutions. These institutions rely on robust methods to support genomics, transcriptomics, and functional studies, fostering innovation and scientific breakthroughs.
• Forensic Applications: The ability to extract high-quality RNA from degraded or limited samples is critical in forensic investigations. This application is expanding as law enforcement agencies seek more accurate and sensitive methods for crime scene analysis, improving evidence reliability.
• Agricultural & Food Testing: RNA extraction plays a vital role in crop research, GMO testing, and food safety assessments. The development of specialized kits for plant and food samples is opening new avenues for ensuring quality control and regulatory compliance in agriculture and food industries.

In summary, these growth opportunities are significantly impacting the RNA extraction and purification market by broadening its application scope, enhancing product innovation, and increasing adoption across diverse sectors. This expansion is driving market growth, fostering technological advancements, and supporting the development of personalized and precision medicine approaches.

RNA Extraction and Purification Market Driver and Challenges

The RNA extraction and purification market is influenced by a variety of technological, economic, and regulatory factors. Advances in biotechnology and molecular diagnostics are fueling demand for efficient RNA extraction methods. Economic growth in healthcare and research sectors increases investment in innovative tools, while regulatory standards ensure quality and safety, shaping market dynamics. However, challenges such as high costs, complex procedures, and regulatory hurdles can impede growth. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape effectively and capitalize on emerging opportunities.

The factors responsible for driving the RNA extraction and purification market include:-

• Technological Advancements: The continuous development of novel extraction techniques and automation tools enhances efficiency, accuracy, and throughput, meeting the increasing demand from research and clinical laboratories. Innovations like magnetic bead-based extraction and automation platforms reduce manual errors and processing time, enabling large-scale studies and personalized medicine applications. These technological improvements are crucial for keeping pace with the rapid growth of genomics and transcriptomics research, thereby significantly expanding market opportunities.
• Rising Prevalence of Infectious Diseases and Cancer: The global increase in infectious diseases and cancer cases drives the need for reliable RNA analysis for diagnostics, prognosis, and research. Accurate RNA extraction is vital for detecting pathogens, gene expression profiling, and biomarker discovery. As healthcare systems prioritize early diagnosis and personalized treatment, demand for high-quality RNA extraction kits and reagents surges, fueling market growth across hospitals, diagnostic labs, and research institutions.
• Growing Adoption of Molecular Diagnostics: The shift towards molecular-based testing methods for disease detection and monitoring is a key driver. RNA extraction is a critical step in these diagnostics, especially for viral infections like COVID-19, where rapid and accurate RNA detection is essential. The increasing adoption of PCR, next-generation sequencing, and other molecular techniques in clinical settings boosts demand for efficient RNA purification solutions, thereby expanding the market.
• Expansion of Research and Development Activities: Increased funding and focus on genomics, transcriptomics, and personalized medicine are propelling R&D activities worldwide. Pharmaceutical and biotech companies invest heavily in RNA-based research to develop new therapies and diagnostic tools. This surge in R&D efforts necessitates advanced RNA extraction and purification technologies, further propelling market growth and innovation.

The challenges in the RNA extraction and purification market are:

• High Cost of Equipment and Reagents: The sophisticated technology involved in RNA extraction often requires expensive equipment and consumables, which can be prohibitive for small laboratories and developing regions. The high costs limit widespread adoption, especially in resource-constrained settings, and can hinder market expansion. Additionally, ongoing expenses for reagents and maintenance add to the financial burden, impacting overall profitability and accessibility.
• Complex Procedures and Technical Expertise: RNA extraction protocols can be intricate, requiring skilled personnel to ensure high yield and purity. Variability in sample types and quality further complicates the process, increasing the risk of contamination and degradation. The need for specialized training and meticulous handling limits the adoption of these technologies in less-equipped laboratories, thereby constraining market growth.
• Regulatory and Standardization Challenges: Stringent regulatory requirements for diagnostic and clinical applications pose hurdles for product approval and market entry. Lack of standardized protocols can lead to inconsistent results, affecting clinical reliability and acceptance. Navigating diverse regulatory landscapes across regions adds complexity and delays product launches, impacting overall market development.

In summary, the RNA extraction and purification market is driven by technological innovations, rising disease prevalence, and expanding research activities, which collectively foster growth and diversification. However, high costs, procedural complexities, and regulatory challenges present significant barriers. These factors collectively shape the market landscape, requiring stakeholders to innovate and adapt to sustain growth and meet evolving demands. The interplay of these drivers and challenges will determine the pace and direction of market development in the coming years.

List of RNA Extraction and Purification Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA extraction and purification companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA extraction and purification companies profiled in this report include-

• Agilent Technologies
• Bio Rad Laboratories
• Danaher
• F. Hoffmann La Roche
• Geno Technology
• HiMedia Laboratories
• Illumina
• New England Biolabs
• Norgen Biotek
• Promega

RNA Extraction and Purification Market by Segment

The study includes a forecast for the global RNA extraction and purification market by product, end use, and region.

RNA Extraction and Purification Market by Product [Value from 2019 to 2031]:

• Kits & Reagents
• Instruments

RNA Extraction and Purification Market by End Use [Value from 2019 to 2031]:

• Hospitals & Diagnostic Centers
• Academic Research Institutes
• Others

RNA Extraction and Purification Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the RNA Extraction and Purification Market

The RNA extraction and purification market has experienced significant growth driven by advancements in biotechnology, increased demand for diagnostic testing, and innovations in molecular research. The COVID-19 pandemic accelerated the adoption of RNA-based diagnostics, prompting technological improvements and expanding market reach globally. Countries are investing heavily in research infrastructure and healthcare capabilities, fostering competitive innovation. Regulatory approvals and collaborations between biotech firms further propel market expansion. As precision medicine and personalized therapies gain prominence, the demand for high-quality RNA extraction solutions continues to rise, shaping the future landscape of this vital sector.

• United States: The US market has seen rapid technological advancements, with major biotech firms launching innovative RNA extraction kits that offer higher efficiency and automation. Increased funding for research institutions and collaborations with pharmaceutical companies have expanded the market. The COVID-19 pandemic boosted demand for diagnostic testing, leading to a surge in RNA extraction product sales. Regulatory agencies have approved several new kits, enhancing market growth. Additionally, the focus on personalized medicine and genomics research has driven demand for high-purity RNA extraction solutions, positioning the US as a market leader.
• China: China has experienced substantial growth in the RNA extraction and purification market, driven by government initiatives to strengthen biotech research and healthcare infrastructure. The country has seen increased adoption of automated extraction systems and the development of domestically produced kits to reduce reliance on imports. The COVID-19 pandemic further accelerated market expansion, with increased testing capacity and research activities. Chinese biotech companies are investing heavily in R&D to develop innovative products, and collaborations with international firms are becoming more common, fostering a competitive and rapidly evolving market landscape.
• Germany: Germany's market is characterized by a focus on high-quality, reliable RNA extraction solutions, supported by a strong biotech and pharmaceutical sector. The country has seen increased adoption of automated and high-throughput extraction systems, especially in clinical diagnostics and research laboratories. Regulatory standards are stringent, ensuring product quality and safety, which has driven innovation in the development of advanced kits. The growing emphasis on personalized medicine and molecular diagnostics has further boosted demand. Germany's strategic collaborations with European and global biotech firms have contributed to technological advancements and market expansion.
• India: The Indian RNA extraction and purification market is rapidly expanding, fueled by increasing investments in healthcare infrastructure and rising awareness of molecular diagnostics. The COVID-19 pandemic significantly increased demand for RNA testing, prompting local manufacturers to develop cost-effective and efficient kits. The government's initiatives to promote biotech research and manufacturing have supported market growth. Additionally, the growing number of research institutions and diagnostic labs adopting automated systems has contributed to market expansion. The focus on affordable healthcare solutions and local production capabilities is expected to sustain growth in the coming years.
• Japan: Japan's market is characterized by technological innovation and a focus on high-quality, reliable RNA extraction solutions. The country has seen increased adoption of automated and high-throughput systems in clinical and research settings. Japan's emphasis on precision medicine and advanced diagnostics has driven demand for superior RNA purification products. The government's support for biotech innovation and collaborations with international firms have facilitated market growth. Additionally, the aging population has increased the need for advanced diagnostic tools, further boosting the market. Continuous R&D investments ensure Japan remains at the forefront of RNA extraction technology development.

Features of the Global RNA Extraction and Purification Market

• Market Size Estimates: Rna extraction and purification market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Rna extraction and purification market size by product, end use, and region in terms of value ($B).
• Regional Analysis: Rna extraction and purification market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products, end uses, and regions for the RNA extraction and purification market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA extraction and purification market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the RNA extraction and purification market by product (kits & reagents and instruments), end use (hospitals & diagnostic centers, academic research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global RNA Extraction and Purification Market by Product

• 4.1 Overview
• 4.2 Attractiveness Analysis by Product
• 4.3 Kits & Reagents : Trends and Forecast (2019-2031)
• 4.4 Instruments : Trends and Forecast (2019-2031)

5. Global RNA Extraction and Purification Market by End Use

• 5.1 Overview
• 5.2 Attractiveness Analysis by End Use
• 5.3 Hospitals & Diagnostic Centers : Trends and Forecast (2019-2031)
• 5.4 Academic Research Institutes : Trends and Forecast (2019-2031)
• 5.5 Others : Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global RNA Extraction and Purification Market by Region

7. North American RNA Extraction and Purification Market

• 7.1 Overview
• 7.2 North American RNA Extraction and Purification Market by Product
• 7.3 North American RNA Extraction and Purification Market by End Use
• 7.4 The United States RNA Extraction and Purification Market
• 7.5 Canadian RNA Extraction and Purification Market
• 7.6 Mexican RNA Extraction and Purification Market

8. European RNA Extraction and Purification Market

• 8.1 Overview
• 8.2 European RNA Extraction and Purification Market by Product
• 8.3 European RNA Extraction and Purification Market by End Use
• 8.4 German RNA Extraction and Purification Market
• 8.5 French RNA Extraction and Purification Market
• 8.6 Italian RNA Extraction and Purification Market
• 8.7 Spanish RNA Extraction and Purification Market
• 8.8 The United Kingdom RNA Extraction and Purification Market

9. APAC RNA Extraction and Purification Market

• 9.1 Overview
• 9.2 APAC RNA Extraction and Purification Market by Product
• 9.3 APAC RNA Extraction and Purification Market by End Use
• 9.4 Chinese RNA Extraction and Purification Market
• 9.5 Indian RNA Extraction and Purification Market
• 9.6 Japanese RNA Extraction and Purification Market
• 9.7 South Korean RNA Extraction and Purification Market
• 9.8 Indonesian RNA Extraction and Purification Market

10. ROW RNA Extraction and Purification Market

• 10.1 Overview
• 10.2 ROW RNA Extraction and Purification Market by Product
• 10.3 ROW RNA Extraction and Purification Market by End Use
• 10.4 Middle Eastern RNA Extraction and Purification Market
• 10.5 South American RNA Extraction and Purification Market
• 10.6 African RNA Extraction and Purification Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Product
  • 12.2.2 Growth Opportunity by End Use
• 12.3 Emerging Trends in the Global RNA Extraction and Purification Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Agilent Technologies
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Bio Rad Laboratories
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Danaher
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 F. Hoffmann La Roche
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Geno Technology
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 HiMedia Laboratories
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Illumina
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 New England Biolabs
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Norgen Biotek
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Promega
  • Company Overview
  • RNA Extraction and Purification Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us